Sanofi India Ltd vs Senores Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3119 as of 12 Jun 15:30 . The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 6 quarters. This represents a CAGR of -100.00% The p/e ratio of Senores Pharmaceuticals Ltd changed from 45 to 45 over 1 quarters. This represents a CAGR of 0.00% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The market cap of Senores Pharmaceuticals Ltd changed from ₹ 2637 crore to ₹ 2637 crore over 1 quarters. This represents a CAGR of 0.00% The revenue of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Senores Pharmaceuticals Ltd for the Mar '26 is ₹ 192.86 crore as compare to the Dec '25 revenue of ₹ 178.34 crore. This represent the growth of 8.14% The ebitda of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Senores Pharmaceuticals Ltd for the Mar '26 is ₹ 65.16 crore as compare to the Dec '25 ebitda of ₹ 57.79 crore. This represent the growth of 12.75% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Senores Pharmaceuticals Ltd changed from ₹ 10.91 crore to ₹ 36.67 crore over 8 quarters. This represents a CAGR of 83.33% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Senores Pharmaceuticals Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
The Regulated Markets business is focused on Regulated Markets of US and Canada.
The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

FAQs for the comparison of Sanofi India Ltd and Senores Pharmaceuticals Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Senores Pharmaceuticals Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Senores Pharmaceuticals Ltd is 5,946 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Senores Pharmaceuticals Ltd?

The stock performance of Sanofi India Ltd and Senores Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Senores Pharmaceuticals Ltd?

As of June 15, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Senores Pharmaceuticals Ltd stock price is INR ₹1291.25.

How do dividend payouts of Sanofi India Ltd and Senores Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Senores Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.